Jewish heirs take legal action against Metropolitan Museum of Art, claiming Vincent van Gogh's 'The Olive Pickers' was looted by Nazis. The high-stakes lawsuit reveals ongoing battles over art restitution.
Tech giant Apple escalates legal war against OPPO, demanding termination of key engineers and seizure of hardware in dramatic courtroom showdown over patent infringement allegations.
Pharmaceutical giant Eli Lilly partners with NVIDIA to deploy cutting-edge AI supercomputers that will accelerate drug development and transform pharmaceutical research.
In an inspiring David vs Goliath story, 78-year-old farmer Sardar Surat Singh Khanda takes a bold stand against actress Kangana Ranaut in Chandigarh court, refusing to compromise his dignity.
The US government shutdown crisis deepens with another failed Senate vote while 25 states file lawsuits against Trump administration's proposed SNAP benefit cuts, threatening millions of Americans.
Former Minnesota Vikings running back Adrian Peterson faces second DWI charge in 2025 after being discovered unconscious in vehicle with firearm at Houston gas station.
The state of Texas has filed a lawsuit against Johnson & Johnson and its spin-off Kenvue, alleging the companies failed to warn consumers about potential autism risks associated with Tylenol use during pregnancy. This legal action comes just weeks after f
Sanofi India announces Deepak Arora as its new Managing Director, bringing extensive pharmaceutical experience to drive growth and innovation in the Indian healthcare market.
India initiates anti-dumping investigation on tuberculosis medication imports from China and Thailand following domestic industry complaints about unfair pricing practices affecting local manufacturers.
Delhi-based pharmaceutical support company SafeCure Services Ltd plans to raise up to ₹60 crore through IPO. Fresh issue of 48 lakh shares priced at ₹60-75 each. Learn key dates and details.
Australian regulator ACCC files lawsuit against Microsoft, claiming the tech giant used artificial intelligence features to justify unfair price increases for software subscriptions, raising concerns about AI-powered pricing strategies.
Australian regulator sues Microsoft for allegedly using AI features to justify unfair price increases for key software subscriptions in what could become a landmark tech antitrust case.
In a major healthcare move, Punjab government prohibits sale of 112 substandard drugs following quality control tests. Find out which medications are affected and what this means for public health safety.
Swiss pharmaceutical giant Novartis AG is finalizing a landmark acquisition of California-based Avidity Biosciences in a deal valuing the biotech firm at over $70 per share, potentially exceeding $1.7 billion, according to exclusive reports.
As the legal drama between Blake Lively and Justin Baldoni intensifies with new court filings, Taylor Swift and Travis Kelce maintain deliberate distance from the controversy. Get the inside scoop on Hollywood's latest legal showdown.
A shocking cryptocurrency scheme allegedly used Melania Trump's identity to promote a pump-and-dump scam that left investors with massive losses. New legal filings reveal how the former First Lady's name became weaponized in digital fraud.
A domestic dispute over household chores escalated dramatically when an Indian-origin woman allegedly attacked her husband with a knife in their Texas home. Police intervention led to her arrest on serious charges.
Narcotics Control Bureau investigates two Punjab Health Department employees for alleged involvement in illegal tramadol distribution network. Shocking revelations emerge during interrogation.
Severe thunderstorms battered Houston with hurricane-force winds, causing catastrophic damage, widespread power outages affecting nearly 150,000 residents, and leaving a trail of destruction across the city.
India's drug regulator CDSCO has flagged 112 medicines for quality violations and issued a nationwide alert about a spurious cough syrup following child fatalities in Madhya Pradesh. Critical safety update for consumers.
Exclusive investigation reveals Donald Trump's White House ballroom events are bankrolled by major corporations including Apple and Coinbase, while his legal battles against YouTube continue.
Discover how Dr. Anji Reddy's visionary journey from generics to innovative drug research positioned India as a global pharmaceutical powerhouse and continues to inspire future generations.
Dr. Reddy's Laboratories delivers stellar Q2 FY25 results, beating revenue and profit forecasts. Discover how their pharmaceutical business and nicotine replacement portfolio drove exceptional performance.
Critical medication alert: Major pharmaceutical recall announced after FDA testing reveals cholesterol-lowering pills may not dissolve properly, potentially compromising effectiveness.
In a major healthcare reform, Uttar Pradesh Chief Minister Yogi Adityanath mandates complete digitalization of drug regulation system and stricter quality control measures to ensure medicine safety across the state.
In a revolutionary healthcare development, Bangladesh's Beximco Pharma launches affordable generic version of lifesaving rare disease drug, dramatically reducing treatment costs from crores to lakhs for patients across South Asia.
Sigachi Industries faces turbulent quarter with net profit crashing to ₹10.5 crore amid significant revenue decline. What's behind the pharmaceutical giant's disappointing performance?
The Trump administration declares it will vigorously defend lawsuits challenging the controversial $100,000 H-1B visa fee increase, setting the stage for a major legal battle over US immigration policy.
Cipla's stock faces unexpected pressure despite securing rights to manufacture and distribute Eli Lilly's revolutionary weight loss drug Mounjaro in India. Discover why investors remain cautious.
Delhi High Court puts temporary stay on NPPA's order restricting 'ORS' branding for manufacturers. JJ Arm and other companies get breathing room in crucial rehydration market.